Global Clinical Chemistry Analyzer Market Driven by Higher Testing Volume and Shorter TAT Due to Automation
In recent decades, the clinical chemistry instrumentation business has seen a rapid evolution of technological improvements. Novel features, such as closed tube sampling, automated maintenance processes, streamlined calibration, and internet-based remote diagnostics, have been introduced with each new system generation. These intend to help laboratories better meet the needs of physicians and patients while creating efficiencies, driving quality, lowering costs, and addressing workforce fluctuations. As a result, the global clinical chemistry analyzer market was valued at over USD 12 billion in 2021 and is anticipated to grow at a CAGR of 4.8% over the forecast period (2022-2030).